Halo Medical operates from a state-of-the-art Research and Manufacturing facility in the West of Ireland. Halo Offers a complete range of services including Auto Transfusion Manufacturing, R&D, Cardiovascular Device Packaging, OEM Support, Subcontract Assembly, CE Marking and Sterilisation Validation. The facility and Manufacturing process are approved to the ISO Medical Device standard ISO IEN 13485.2003.
Located in the heart of Irelands “Life Science” Industry, Halo is about to launch the “Betatrans” Autotransfusion device. With its unique features and benefits and significant price advantage, the Betatrans is destined to be a World Leader. The initial sales drive will be to the EU & USA, with global markets to follow via strategic Distribution partners. Additional R & D programs, with IP, are also planned, to vertically and horizontally expand Halo’s business model, including the “Halotrans” portable Autotransfusion device.
Halo’s aim is to produce a Cost-Effective, High Value Range of Products and Services whilst creating competitive advantage to its customers and maximum returns to its Investors and Shareholders
